Sign in
XXII Stock Price, Chart, Stats & News
22nd Century Group, Inc.
Save
82,121
Market cap
–
Current P/E
–
Forward P/E
XXII chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -20.24% |
Operating margin | -64.91% |
Pretax margin | -74.74% |
Net margin | -28.74% |
Effective tax rate | 0.21% |
ROA | -18.70% |
ROE | -43.84% |
D/E | 0.27x |
Interest coverage ratio | -7.85x |
XXII valuation
P/E | – |
P/S | 0.02x |
P/B | 0.03x |
P/CF | -0.06x |
P/FCF | -0.05x |
P/OCF | -0.06x |
PEG | -0.00x |
EV multiple | -0.33x |
About
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.
Similar securities
Based on sector and market capitalization
Report issue